Par Pharmaceutical Engaged in Illegal Drug-Switching Scheme, U.S. Says—9/6/11

In a whistleblower lawsuit, the U.S. alleges that a leading company in drug making and distribution defrauded government healthcare systems by engaging in a nationwide illegal drug-switching scheme. The whistleblower lawsuit became public this week in a Chicago federal court. Twenty states and the District of Columbia have joined the lawsuit filed under the False Claims Act.

Read more at: